(Q58434978)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17371319%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

title

Long-term treatment of plaque psoriasis with efalizumab: an Italian experience (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17371319%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17371319%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Ketty Peris

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17371319%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Marina Talamonti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17371319%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Maria Concetta Fargnoli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17371319%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

A Di Cesare

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17371319%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

E Botti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17371319%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

S Chimenti

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17371319%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

language of work or name

English

0 references

publication date

1 April 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17371319%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Dermatology

27 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17371319%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

156 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17371319%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

s2

0 references

page(s)

17-23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17371319%20AND%20SRC:MED&resulttype=core&format=json

Extended efalizumab therapy improves chronic plaque psoriasis: results from a randomized phase III trial.

27 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07765.X

Efalizumab: a review of events reported during clinical trials and side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07765.X

Relapse, rebound, and psoriasis adverse events: an advisory group report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07765.X

21 January 2018

Efalizumab: an overview

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07765.X

A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07765.X

10.1111/J.1365-2133.2007.07765.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17371319%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference